Biomarkers: New Advances in Diabetic Nephropathy
Open Access
- 21 February 2025
- journal article
- Published by SAGE Publications in Natural Product Communications
- Vol. 20 (2)
Abstract
Diabetic nephropathy (DN) is the leading cause of uremia and clinical mortality, characterized by the progressive deterioration of kidney structure and function due to prolonged exposure to hyperglycemia. This condition often necessitates renal replacement therapy for patients with end-stage-renal-disease (ESRD). Consequently, early detection, diagnosis, and treatment of DN are crucial to mitigate disease progression, enhance patient outcomes, and maintain a good quality of life. Exploring relevant biomarkers for the early diagnosis of DN holds significant importance. In recent years, numerous researchers have identified various novel biomarkers associated with diabetic nephropathy, which are critical for predicting both the onset and progression of the disease. This article aims to provide a comprehensive overview of the biomarkers related to DN.Keywords
Funding Information
- National Natural Science Foundation of China (81473427)
- Xinglin Talent Program of Chengdu University of Traditional Chinese Medicine (QJJJ2023017)
- Sichuan Provincial Science and Technology Program (2021YJ0112)
- Scientific Research Project of Sichuan Provincial Administration of Traditional Chinese Medicine (2024MS046)
This publication has 142 references indexed in Scilit:
- Screening candidate diagnostic biomarkers for diabetic kidney diseaseJournal of Clinical Laboratory Analysis, 2024
- Salivary microbiome in kidney diseases: A narrative reviewCell Biochemistry and Function, 2023
- Profile of plasma free amino acids, carnitine and acylcarnitines, and JAK2v617f mutation as potential metabolic markers in children with type 1 diabetic nephropathyBiomedical Chromatography, 2023
- Proteomics and Biomarkers for Kidney Diseases Diagnosis2022
- Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetesDiabetologia, 2021
- Rapid and sensitive detection of L‐FABP for prediction and diagnosis of acute kidney injury in critically ill patients by chemiluminescent immunoassayJournal of Clinical Laboratory Analysis, 2021
- Urinary Proteomics as a Tool to Identify Kidney Responders to Dipeptidyl Peptidase‐4 Inhibition: A Hypothesis‐Generating Analysis from the MARLINA‐T2D TrialProteomics – Clinical Applications, 2019
- Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre studyDiabetologia, 2018
- Plasma concentrations of 8-hydroxy-2′-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetesDiabetologia, 2017
- Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetesDiabetologia, 2017